# An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

> **NCT00210652** · PHASE2 · COMPLETED · sponsor: **SK Life Science, Inc.** · enrollment: 47 (actual)

## Conditions studied

- Epilepsy
- Epilepsies, Partial

## Interventions

- **DRUG:** RWJ 333369:

## Key facts

- **NCT ID:** NCT00210652
- **Lead sponsor:** SK Life Science, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2013-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00210652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00210652, "An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00210652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*